Cyclosporin a binding to calmodulin: A possible site of action on T lymphocytes

Research output: Contribution to journalArticlepeer-review

191 Scopus citations


Cyclosporin A, a potent immunosuppressive agent, has been widely used to treat patients with solid organ transplants. Although its precise mechanism of action is unknown, it appears to inhibit subsets of T lymphocytes at an early stage in cell activation. Fluorescent, fully active derivatives of cyclosporin A and calmodulin, a protein that binds calcium and is therefore essential to normal cell function, were utilized to demonstrate that cyclospotin A binds to calmodulin. Flow cytometry showed that the calmodulin inhibitors R24571 and W-7 competitively inhibited binding of cyclosporin A to cloned T lymphocytes. Cyclosporin A inhibited the calmodulin-dependent activation of phosphodiesterase in a dose-dependent manner. Binding of cyclosporin A to calmodulin may prevent the latter's role in the activation of the second messengers and enzymes required for effective cell proliferation and function in the immune response.

Original languageEnglish (US)
Pages (from-to)337-339
Number of pages3
Issue number4697
StatePublished - 1985

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Cyclosporin a binding to calmodulin: A possible site of action on T lymphocytes'. Together they form a unique fingerprint.

Cite this